MDM2 and urinary bladder carcinoma: Sakano S et al [26] comprised of 101 bladder cancer patients treated with platinum-based chemoradiotherapy, and seven polymorphisms in XPC, XPD, XPG, XRCC1, XRCC3, TP53 and MDM2 were genotyped.